Hypoglycaemia is the commonest side effect of insulin and sulfonylureas in the treatment of all types of diabetes and presents a major barrier to satisfactory long term glycaemic control. Hypoglycaemia results from an imbalance between glucose supply, glucose utilisation and current insulin levels.
Fifteen per cent of inpatients in England and Wales have known diabetes. The hospital environment presents additional obstacles to the maintenance of good glycaemic control and the avoidance of hypoglycaemia.
These guidelines, produced by the Joint British Diabetes Societies - Inpatient Care Group (JBDS-IP), are intended for use by clinicians and service commissioners to advise the treatment and hospital management of hypoglycaemia in adults with diabetes.